Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Adenoid Cystic | 7 | 2019 | 263 | 2.120 |
Why?
|
Mucous Membrane | 4 | 2018 | 670 | 1.560 |
Why?
|
Head and Neck Neoplasms | 13 | 2022 | 2745 | 1.550 |
Why?
|
Otorhinolaryngologic Neoplasms | 3 | 2015 | 27 | 1.260 |
Why?
|
Carcinoma, Mucoepidermoid | 2 | 2022 | 98 | 1.070 |
Why?
|
Melanoma | 6 | 2021 | 5260 | 0.920 |
Why?
|
Salivary Gland Neoplasms | 2 | 2022 | 296 | 0.860 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2018 | 243 | 0.690 |
Why?
|
Nose Neoplasms | 2 | 2018 | 249 | 0.670 |
Why?
|
Keloid | 1 | 2017 | 49 | 0.640 |
Why?
|
Ear, External | 1 | 2017 | 164 | 0.610 |
Why?
|
SOXB1 Transcription Factors | 1 | 2018 | 296 | 0.590 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2018 | 144 | 0.590 |
Why?
|
Salivary Proteins and Peptides | 1 | 2016 | 60 | 0.580 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2018 | 1841 | 0.560 |
Why?
|
Kallikreins | 1 | 2016 | 267 | 0.540 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 628 | 0.500 |
Why?
|
Neck | 1 | 2018 | 710 | 0.480 |
Why?
|
Head | 1 | 2018 | 852 | 0.460 |
Why?
|
Skin Transplantation | 1 | 2018 | 1123 | 0.450 |
Why?
|
Respiratory Mucosa | 1 | 2015 | 462 | 0.440 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2022 | 4038 | 0.410 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2021 | 8944 | 0.410 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3564 | 0.370 |
Why?
|
Biopsy, Fine-Needle | 1 | 2014 | 1063 | 0.370 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8925 | 0.330 |
Why?
|
Melanoma-Specific Antigens | 2 | 2017 | 84 | 0.300 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3698 | 0.290 |
Why?
|
Neoplasm Staging | 6 | 2018 | 11200 | 0.280 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2019 | 8685 | 0.250 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2022 | 67 | 0.220 |
Why?
|
Odontogenic Tumors | 1 | 2021 | 42 | 0.220 |
Why?
|
Birt-Hogg-Dube Syndrome | 1 | 2022 | 40 | 0.220 |
Why?
|
Prognosis | 10 | 2022 | 29226 | 0.190 |
Why?
|
Papillomavirus Infections | 2 | 2022 | 1516 | 0.190 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2021 | 235 | 0.190 |
Why?
|
Antigens, Neoplasm | 3 | 2017 | 2004 | 0.190 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 198 | 0.190 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 392 | 0.190 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9597 | 0.180 |
Why?
|
Neoplasm Invasiveness | 3 | 2017 | 3704 | 0.180 |
Why?
|
Alphapapillomavirus | 1 | 2022 | 227 | 0.180 |
Why?
|
Ecosystem | 1 | 2023 | 427 | 0.170 |
Why?
|
Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 177 | 0.170 |
Why?
|
Disease-Free Survival | 4 | 2016 | 7056 | 0.170 |
Why?
|
Pharyngeal Neoplasms | 1 | 2018 | 120 | 0.170 |
Why?
|
Retrospective Studies | 10 | 2022 | 72608 | 0.160 |
Why?
|
Eye, Artificial | 1 | 2017 | 22 | 0.160 |
Why?
|
Neoplasm Proteins | 3 | 2021 | 3778 | 0.160 |
Why?
|
Triamcinolone | 1 | 2017 | 67 | 0.160 |
Why?
|
Vimentin | 1 | 2018 | 276 | 0.160 |
Why?
|
Prosthesis Fitting | 1 | 2017 | 78 | 0.160 |
Why?
|
Laryngostenosis | 1 | 2019 | 157 | 0.160 |
Why?
|
Middle Aged | 17 | 2021 | 215054 | 0.160 |
Why?
|
Software Design | 1 | 2017 | 181 | 0.150 |
Why?
|
Tracheal Stenosis | 1 | 2019 | 221 | 0.150 |
Why?
|
Seroepidemiologic Studies | 3 | 2023 | 378 | 0.150 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2022 | 1615 | 0.150 |
Why?
|
Algorithms | 1 | 2017 | 13716 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6777 | 0.150 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2022 | 463 | 0.150 |
Why?
|
DNA Methylation | 2 | 2021 | 4102 | 0.150 |
Why?
|
Humans | 39 | 2023 | 717280 | 0.150 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13754 | 0.150 |
Why?
|
Vital Capacity | 1 | 2019 | 912 | 0.150 |
Why?
|
Translocation, Genetic | 1 | 2022 | 1426 | 0.150 |
Why?
|
Transplants | 1 | 2018 | 207 | 0.140 |
Why?
|
Neck Dissection | 1 | 2017 | 219 | 0.140 |
Why?
|
Antibodies, Viral | 3 | 2022 | 3010 | 0.140 |
Why?
|
Mouth Mucosa | 1 | 2018 | 432 | 0.140 |
Why?
|
Nasal Mucosa | 1 | 2018 | 367 | 0.140 |
Why?
|
Larynx, Artificial | 1 | 2015 | 68 | 0.140 |
Why?
|
Female | 20 | 2021 | 377934 | 0.130 |
Why?
|
Therapy, Computer-Assisted | 1 | 2017 | 275 | 0.130 |
Why?
|
Trans-Activators | 2 | 2022 | 3069 | 0.130 |
Why?
|
Parotid Neoplasms | 1 | 2015 | 162 | 0.130 |
Why?
|
Male | 18 | 2021 | 351399 | 0.130 |
Why?
|
Interferon-alpha | 1 | 2018 | 898 | 0.130 |
Why?
|
Pressure | 1 | 2017 | 1240 | 0.130 |
Why?
|
Forced Expiratory Volume | 1 | 2019 | 1725 | 0.120 |
Why?
|
Lymphatic Metastasis | 3 | 2017 | 2975 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1395 | 0.120 |
Why?
|
Laryngectomy | 1 | 2015 | 234 | 0.120 |
Why?
|
Prospective Studies | 5 | 2022 | 51277 | 0.120 |
Why?
|
Central Nervous System Neoplasms | 1 | 2021 | 869 | 0.120 |
Why?
|
Cadherins | 1 | 2018 | 917 | 0.120 |
Why?
|
Prosthesis Design | 2 | 2017 | 2144 | 0.120 |
Why?
|
Mouth Neoplasms | 1 | 2018 | 609 | 0.120 |
Why?
|
Immunoenzyme Techniques | 1 | 2016 | 1845 | 0.110 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2018 | 794 | 0.110 |
Why?
|
Tracheostomy | 1 | 2015 | 400 | 0.110 |
Why?
|
Aged | 11 | 2021 | 162862 | 0.110 |
Why?
|
Patient Care Planning | 1 | 2017 | 936 | 0.100 |
Why?
|
Immunologic Factors | 2 | 2018 | 1575 | 0.100 |
Why?
|
Clinical Protocols | 1 | 2017 | 1474 | 0.100 |
Why?
|
Artificial Intelligence | 1 | 2023 | 1740 | 0.100 |
Why?
|
Treatment Failure | 1 | 2017 | 2678 | 0.100 |
Why?
|
Prosthesis Implantation | 1 | 2015 | 666 | 0.100 |
Why?
|
Nuclear Proteins | 2 | 2022 | 5988 | 0.090 |
Why?
|
Photochemotherapy | 1 | 2016 | 829 | 0.090 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2594 | 0.090 |
Why?
|
Membrane Proteins | 2 | 2016 | 8109 | 0.090 |
Why?
|
Genetic Markers | 1 | 2014 | 2692 | 0.080 |
Why?
|
Transcription Factors | 3 | 2022 | 12073 | 0.080 |
Why?
|
Immunohistochemistry | 3 | 2017 | 11777 | 0.080 |
Why?
|
DNA-Binding Proteins | 2 | 2022 | 9804 | 0.080 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 6051 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2017 | 1801 | 0.080 |
Why?
|
Mutation | 3 | 2021 | 29491 | 0.080 |
Why?
|
Equipment Design | 1 | 2014 | 3631 | 0.070 |
Why?
|
Biological Products | 1 | 2014 | 842 | 0.070 |
Why?
|
Recurrence | 1 | 2017 | 8284 | 0.070 |
Why?
|
Papillomaviridae | 2 | 2022 | 1144 | 0.070 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2017 | 2127 | 0.060 |
Why?
|
Immunotherapy | 2 | 2017 | 4137 | 0.060 |
Why?
|
Hematologic Neoplasms | 1 | 2014 | 1701 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15271 | 0.060 |
Why?
|
Adult | 9 | 2022 | 212470 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5335 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2014 | 3433 | 0.060 |
Why?
|
Submandibular Gland | 1 | 2022 | 92 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2865 | 0.060 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7497 | 0.050 |
Why?
|
Survival Rate | 1 | 2016 | 13262 | 0.050 |
Why?
|
Conjunctival Neoplasms | 1 | 2021 | 87 | 0.050 |
Why?
|
RNA-Binding Protein EWS | 1 | 2021 | 210 | 0.050 |
Why?
|
Disease Progression | 1 | 2017 | 13308 | 0.050 |
Why?
|
Remote Sensing Technology | 1 | 2021 | 95 | 0.050 |
Why?
|
Cohort Studies | 5 | 2022 | 39891 | 0.050 |
Why?
|
Blood Specimen Collection | 1 | 2021 | 247 | 0.050 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 633 | 0.050 |
Why?
|
MicroRNAs | 1 | 2015 | 3680 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 13276 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2018 | 62344 | 0.040 |
Why?
|
Fingers | 1 | 2021 | 521 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2021 | 3471 | 0.040 |
Why?
|
Suture Anchors | 1 | 2017 | 75 | 0.040 |
Why?
|
Inflammation | 1 | 2016 | 10116 | 0.040 |
Why?
|
Epitopes | 1 | 2022 | 2657 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2022 | 2661 | 0.040 |
Why?
|
Computer-Aided Design | 1 | 2017 | 266 | 0.040 |
Why?
|
Parotid Gland | 1 | 2015 | 163 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 942 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14904 | 0.030 |
Why?
|
DNA, Viral | 1 | 2022 | 2293 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58528 | 0.030 |
Why?
|
CpG Islands | 1 | 2019 | 1162 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1671 | 0.030 |
Why?
|
Facial Nerve | 1 | 2017 | 276 | 0.030 |
Why?
|
Androgens | 1 | 2022 | 1231 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15126 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1671 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39302 | 0.030 |
Why?
|
Kinetics | 1 | 2022 | 6805 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2015 | 229 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 20572 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1836 | 0.030 |
Why?
|
Testis | 1 | 2016 | 809 | 0.030 |
Why?
|
Materials Testing | 1 | 2015 | 873 | 0.030 |
Why?
|
Laryngeal Neoplasms | 1 | 2015 | 540 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2016 | 1679 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8068 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2017 | 1233 | 0.020 |
Why?
|
Computer Simulation | 1 | 2023 | 6100 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3565 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2017 | 1635 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2015 | 1826 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3372 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4312 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 4874 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4030 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19537 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2017 | 12484 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9532 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10542 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 23409 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16989 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12416 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 13301 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 7292 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 16020 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23543 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20435 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 23997 | 0.010 |
Why?
|
Concepts
(184)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(92)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_